LifePlus announced the clinical validation of its non-invasive and cuffless wearable for continuous glucose and blood ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

For many, a partnership between Abbott and Medtronic, two medtech giants and frequent competitors, would have seemed unlikely ...

The system — similar to continuous glucose monitoring (CGM) uses a new method of continuously sensing specific chemistry ...

BTIG analysts said today that Beta Bionics expects to launch a new insulin patch pump system in the U.S. by the end of 2027.

Vaxess Technologies today shared new preclinical data highlighting the capability of its drug delivery patch to deliver ...

(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...

BTIG analysts said today that MiniMed, the Medtronic (NYSE:MDT) diabetes business, has some significant pipeline updates.

One of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its ...

It's been a busy couple of years for Tandem Diabetes Care (Nasdaq:TNDM) and it doesn't look like slowing down any time soon.

Dexcom (Nasdaq:DXCM) has shared a new report highlighting access and attitudes toward type 2 diabetes in the U.S.